New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial data show

In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the ...
Morningstar

Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations

Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...

UW discovers new oral solution that yields better visuals for CT scans

The University of Washington says researchers have developed a new oral contrast agent that produces better images during CT scans.
Healio

Anaphylaxis caused by iodinated contrast media rare but still serious

Anaphylaxis triggered by iodinated contrast media was rare, but severe and refractory cases indicated the need for ...
Yahoo Finance

Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations

Follows recent FDA clearance to expand the use of compatible contrast agent presentations, adding single-dose vials in addition to Imaging Bulk Package presentations Radiology suites now have the ...
Nasdaq

Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations

Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...